Over 900 genes have been implicated in the resistance of tumors to platinum-based chemotherapy that map to many different cellular pathways, thwarting efforts to identify a biomarker to predict refractoriness. Attacking these complex molecular phenotypes requires moving to next-generation molecular diagnostics capable of recognizing different networks of proteins that collectively describe, in advance, all cancer […]
